Study title: Evaluation of anthroposophic supportive medicine on treatment -related toxicity in children receiving cancer therapy.
Type of medicine: Herbal and homoeopathic medicines | |||||
Therapeutic area: | |||||
Brands: Please see report | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: acqueous extract(1:20) from fresh herb of white-berry mistletoe (Viscum album L.): HELIXOR® A: produced from mistletoe growing on fir (Viscum album L. abietis), HELIXOR® M: produced from mistletoe growing on apple tree (Viscum album L. mali), HELIXOR® P: produced from mistletoe growing on pine (Viscum album L. pini) | |||||
ATC code: L01CP01 | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: 2004-002711-83 | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |